![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Loeck, Steffen; Linge, Annett; Lohaus, Fabian; Ebert, Nadja; Gudziol, Volker; Nowak, Alexander; Tinhofer, Ingeborg; Kalinauskaite, Goda; Guberina, Maja; Stuschke, Martin; Balermpas, Panagiotis; Gruen, Jens von der; Grosu, Anca-Ligia; Debus, Juergen; Ganswindt, Ute; Belka, Claus; Peeken, Jan C.; Combs, Stephanie E.; De-Colle, Chiara; Zips, Daniel; Baretton, Gustavo B.; Krause, Mechthild und Baumann, Michael
(2022):
Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - Hypothesis generation on a multicentre cohort of the DKTK-ROG.
In: Radiotherapy and Oncology, Bd. 169: S. 8-14
Guberina, Maja; Sak, Ali; Poettgen, Christoph; Tinhofer-Keilholz, Ingeborg; Budach, Volker; Balermpas, Panagiotis; Gruen, Jens von der; Roedel, Claus Michael; Gikka, Eleni; Grosu, Anca-Ligia; Abdollahi, Amir; Debus, Jürgen; Belka, Claus; Pigorsch, Steffi; Combs, Stephanie; Moennich, David; Zips, Daniel; De-Colle, Chiara; Welz, Stefan; Linge, Annett; Lohaus, Fabian; Baretton, Gustavo; Gauler, Thomas; Baumann, Michael; Krause, Mechthild; Schuler, Martin; Bankfalvi, Agnes; Hoeing, Benedikt; Lang, Stephan und Stuschke, Martin
(2020):
ERCC2gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy.
In: Pharmacogenomics Journal, Bd. 21, Nr. 1: S. 37-46
De-Colle, Chiara; Menegakis, Apostolos; Moennich, David; Welz, Stefan; Boeke, Simon; Sipos, Bence; Fend, Falko; Mauz, Paul-Stefan; Tinhofer, Inge; Budach, Volker; Abu Jawad, Jehad; Stuschke, Martin; Balermpas, Panagiotis; Rodel, Claus; Grosu, Anca-Ligia; Abdollahi, Amir; Debus, Jürgen; Belka, Claus; Ganswindt, Ute; Pigorsch, Steffi; Combs, Stephanie E.; Lohaus, Fabian; Linge, Annett; Krause, Mechthild; Baumann, Michael und Zips, Daniel
(2018):
SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy.
In: Radiotherapy and Oncology, Bd. 126, Nr. 1: S. 125-131